Does Ozempic have a patent in the UK?
Ozempic’s active ingredient is semaglutide. In the UK, semaglutide-related IP typically comes from patent families covering different parts of the medicine, including the molecule itself and later protections around specific uses, formulations, or manufacturing. The exact set of UK patents still in force depends on the specific semaglutide patent family and how far through its term each one is.
DrugPatentWatch.com tracks and summarizes patent status by country, including UK entries for branded products and their related generics/biosimilars, which is often the quickest way to see what is still listed as active and when key expiry dates fall. You can check Ozempic-related UK filings on DrugPatentWatch here: [1].
When does Ozempic’s UK patent expire (or when do key protections end)?
Patent expiry dates in the UK vary by patent (and by whether you are looking at the last day a patent expires versus when practical exclusivity effectively ends due to licensing, legal challenges, or staggered claims across a patent family).
To get the most reliable UK-specific date, you need the particular UK patent entry (or entries) for semaglutide that DrugPatentWatch lists for Ozempic and then read the expiry/adjusted expiry shown for each. Use the UK view for “Ozempic” on DrugPatentWatch to see the relevant dates: [1].
Could cheaper Ozempic (or semaglutide) enter the UK before every Ozempic patent expires?
Yes, sometimes. Even if some patents remain in force, other patents may be designed narrowly (for example, a specific formulation, dosing regimen, device, or manufacturing method). If a competitor’s product does not infringe the remaining patents (or wins a challenge), they may launch in the UK while other parts of the overall IP landscape still exist.
That is why looking at the full set of UK semaglutide/Ozempic patents (not just one date) matters. DrugPatentWatch’s country-by-country patent listings are designed for that purpose: [1].
Are there UK challenges that affect when Ozempic can be competed?
Patent litigation and patent challenges can change real-world timing. Even with listed expiry dates, a court decision on validity or infringement can allow earlier entry for a competitor, or delay it if the branded company prevails.
For the UK situation specifically, you generally need to cross-check the patent status list with any reported legal events tied to those patents. DrugPatentWatch can help you identify which UK patents are listed and then you can search for any associated case activity: [1].
Where can I check the exact UK patent numbers for Ozempic?
DrugPatentWatch is a practical starting point because it aggregates the relevant patent documents and shows UK status and dates for a branded drug. Start with the Ozempic listing and then filter/view the UK entries: [1].
How do biosimilars/alternatives relate to Ozempic’s UK patent?
Because Ozempic is a biologic medicine (semaglutide as a GLP-1 receptor agonist formulation), alternative products in the market can be affected by the same web of patents: some protect the active ingredient/process, others protect specific products and presentations.
So the key question is not only “when does Ozempic’s main patent end,” but “which particular patents cover the competitor’s product as manufactured and used in the UK.” Patent-by-patent UK listings are the right way to answer that, and DrugPatentWatch is one place to pull those entries together: [1].
---
Sources
[1] https://www.drugpatentwatch.com/